About Isto Biologics
Isto Biologics was formed in 2016 when St. Louis-based Isto Technologies and Arteriocyte Medical Systems Inc. of Hopkinton, Massachusetts, joined forces under the Isto Holdings umbrella. Isto Biologics is focused on offering evidence-based solutions for bone regeneration and cell therapy to help improve patient outcomes. The company’s best-in-class product offerings include Arteriocyte’s market-leading Magellan® Autologous Platelet Separator and Isto’s bone-growth and cell-therapy products including InQu® Bone Graft Extender & Substitute; and Influx™, a natural bone-graft material.
|
|
|
51-200 employees
View all Isto Biologics employees
|
|
Medical Devices
|
|
45 South Street, Hopkinton, MA 01748, US
|
|
1997
|
|
Platelet Rich Plasma, Medical Device, Regenerative Medicine, Bone Grafts, Orthobiologics, Cell-Therapy, Minimally Invasive Spine And Orthopedic Solutions, Products For Spine And Orthopedics, Spinal Disc Regeneration
|
Isto Biologics Alternatives
Frequently Asked Questions about Isto Biologics
The decision makers in Isto Biologics (Formerly Arteriocyte) are Christine Schroeder, Joshua Samberg, Lindsay Fello Murphy, etc. Click to Find Isto Biologics (Formerly Arteriocyte) decision makers emails.
Isto Biologics Staff Directory
Search Isto Biologics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
